Janus kinase/signal transducer and activator of transcription pathway in schizophrenia (Review)

Emmanouil Rizos1, Christos Theleritis1, James N Tsoporis2

  • 1Second Department of Psychiatry, Attikon University General Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece.

Biomedical Reports
|December 8, 2025
PubMed

Insights

This review explores the Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Psychiatry

Background:

  • Schizophrenia is a complex mental disorder impacting cognition, emotion, and behavior.
  • The Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway is frequently dysregulated in schizophrenia.
  • Inflammation, driven by signaling pathway dysregulation, is crucial in schizophrenia's onset and progression.

Purpose of the Study:

  • To provide an overview of dysregulated signaling in schizophrenia.
  • To focus on the role of the JAK/STAT pathway in schizophrenia.
  • To highlight the potential of JAK/STAT research for therapeutic strategies.

Main Methods:

  • Literature review of studies on signaling pathways in schizophrenia.
  • Focus on research detailing JAK/STAT pathway involvement.
  • Analysis of the link between JAK/STAT dysregulation and schizophrenia pathophysiology.

Main Results:

  • The JAK/STAT pathway is implicated in key processes like neurogenesis, gliogenesis, synaptic plasticity, and microglia activation in schizophrenia.
  • Dysregulation of this pathway contributes to inflammation, a critical factor in the disorder.
  • Evidence suggests a multifaceted role for JAK/STAT signaling in the complex mechanisms of schizophrenia.

Conclusions:

  • The JAK/STAT pathway is a significant player in schizophrenia pathogenesis.
  • Understanding JAK/STAT dysregulation offers insights into schizophrenia's inflammatory and cellular processes.
  • Targeting JAK/STAT components may lead to novel therapeutic interventions for schizophrenia.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
11.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.3K
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
467
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.2K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.8K